France injectes Pfizer or Modern’s vacancies at the age of 55 and receives a dose of AstraZeneca | Sociedad

France will inject Pfizer or Moderna vacancies at the age of 55, which will receive a first dose of AstraZeneca. As it has been recommended by the High Health Authority (HAS), the body is responsible for authorizing medicines in countries and cities that are subject to the vacancy of Emmanuel Macron’s Governor. The organism responds to the dictates of the European Medicines Agency (EMA, by its rules in English), that these miracles confirm the angles of the drug with very rare cases of thrombi, although the benefits of the superior immunization with rgos . The Minister of Health, Olivier Véran, has stated that the new protocol, which is considered “logical”, will be adopted immediately.

More information

“In view of the fact that the administration of a single dose of AstraZeneca is insufficient to guarantee effective protection in a timely manner, HAS recommends completing the vacancy calendar for this publication with an ARN message vacancy [Pfizer y Moderna] in a plaza of 12 weeks during the first injection ”, the organism signals in its conclusions, present these days.

“It is totally coherent to say ‘we do not recommend the AstraZeneca vaccine for less than 55 years to the most severe hope’ (…), as we have received a first injection and have less than 55 years, it is propose another vacuna 12 weeks after the first injection; usted will receive a vacancy ARN ”, explained Véran Poco antes in the broadcast RTL.

The drug affects up to 500,000 people who have received the first dose of the Anglo-Saxon vaccine and produce rare cases of thrombosis, which is why it has limited the oath of its receptor. Good part of the minorities of 55 years he received a first injection of this pharmacy his sanitary staff. “I have the same form as his people,” the minister and neurologist recorded, 41 years ago, when he was evacuated.

The HAS states that it has “numerous arguments” in favor of the strategy of inoculating different and signaled vacancies and that it has realized “in the context of the development of vacancy certificates, in particular the VIH”. In addition, it states that pharmacists “currently use the majority in cases of de-escalation for the anti-SARS-CoV-2 actuation prior to the antigen (protein S) action, which may support this strategy”. However, the body recommends “expeditiously” a study to “evaluate in real time the humanitarian response that the recommended mixed evacuation scheme”, as well as to carry out a “specific pharmacovigilance follow-up” for these individuals.

The president of the HAS evacuation technical commission, Elisabeth Bouvet, defended this strategy in favor of recommending all the dosing process with another vacancy ARN, arguing that the persons he received were a dose of AstraZeneca “he produced anticuerpos y tienen un cierta memoire munitaria que la vacuna ARN recordará ”. For this reason, aggregate in the telematic press, “probably a single dose (of ARN) should bastar”. As such, it is necessary for them to have an immediate follow-up of these people. The first dates, signal, deberían conocerse “some weeks” after that the affected hayan received this second dose.

Without embarrassment, the World Health Organization (OMS) has reiterated that it can not make a recommendation on this strategy. “I do not have adequate data to decide if this is something that can be done,” said Margaret Harris, spokesman for the body, because “the interchange of vacancies is not something that can be recommended at this time.”

Solo para mayores de 55

France, together with a fifth European country between Spain and Spain, has been suspended since March by the AstraZeneca car administration, as it has been known to produce some rare cases of thrombosis in patients across Europe. When the European Medicines Agency takes its toll on France, it will be back on March 19th, at the age of 55. A strategy that will not change because “currently we do not have enough arguments to modify this limit”, said the president of the HAS, Dominique Le Guludec.

It is responsible for subordinating the importance of continuing the vacancy campaign and that the mayors of that edict sign accept this vacancy, in order for France not to impose editions limits from the 55 years. We recommend the vacancy with AstraZeneca to the mayors of 55 years. It is a vacancy and the wealth of grave forms of covid has increased significantly with the oath “, Le Guludec recorded presenting the recommendations. “Hi, for the mayors, what is important is the risk of infection with SARS-COV-2. This vaccine will save lives, and if we want to win the battle against the virus, we will use all our arms at our disposal “, insisted.

The organism’s decision is known when France overpowers the barrier of 10 million of the first dose administered, this is one week before the end of the Gobierno season. About 3.5 million people have received the doses. According to the official calendar, up to 20 million people have received a first dose in France in recent Mayo mediations. An “ambitious goal, but we need ambition”, said in respect of Véran. France abrió this week in all the country 38 vacunodromos, in the brand of its policy to accelerate a campaign that has begun the provocation of critical numbers in January.